MMP3, also known as stromelysin-1, has been associated with pathogenesis of neurodegenerative disease including Alzheimer's disease (AD) and Parkinson's disease (PD)[16], [17]. This evidence concerns the gene MMP3 and early-onset autosomal dominant Alzheimer disease.